OKYO Pharma Limited (OKYO) vs Oncolytics Biotech Inc. (ONCY)

A side-by-side comparison of OKYO Pharma Limited and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
OKYO Pharma Limited logo
OKYO
OKYO Pharma Limited
$56M
$1.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Oncolytics Biotech Inc. logo
ONCY
Oncolytics Biotech Inc.
$60M
$0.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — OKYO vs ONCY

growth of $100 · dividends reinvested · last 4y
OKYO -59.4% (-20.2%/yr)ONCY -48.1% (-15.1%/yr)ONCY compounded faster over this window
50100150200250Start $1002023202420252026$41$52
OKYO ONCY

OKYO vs ONCY: by the numbers

  • •ONCY is the larger company ($60M vs $56M market cap).

Metrics side by side

Valuation

MetricOKYOONCY
P/B ratio4.54N/A

Profitability

MetricOKYOONCY
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-72.55%N/A
ROIC-68.91%-1235.48%

Growth (annualized)

MetricOKYOONCY
Total return CAGR (5Y)N/A-21.00%

Go deeper

Full OKYO analysisFull ONCY analysisInteractive comparison tool

Dig into the metrics

OKYO Pharma ROEOncolytics Biotech ROEOKYO Pharma operating marginOncolytics Biotech operating marginOKYO Pharma revenue growthOncolytics Biotech revenue growthOKYO Pharma free cash flowOncolytics Biotech free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.